Journal
JOURNAL OF DERMATOLOGICAL TREATMENT
Volume 33, Issue 2, Pages 1104-1106Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/09546634.2020.1781041
Keywords
COVID; hydroxychloroquine; prophylaxis; urticaria; pruritis; maculopapular rash; antihistamines
Categories
Ask authors/readers for more resources
This article reports cases of palmoplantar among health care workers on prophylactic doses of hydroxychloroquine and discusses their management with cetirizine and methylprednisolone.
The utility of hydroxychloroquine for the prophylaxis and treatment of alarmingly rising COVID-19 infection has been widely explored in several studies. However, its cutaneous adverse effects among health care workers and COVID patients taking prophylactic doses has not been reported. We report cases of palmoplantar among health care workers who were on prophylactic doses of hydroxychloroquine and their management with cetirizine and methylprednisolone.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available